0.9274  -0.123 (-11.68%)		12-15 15:59
Open: 1.09 High: 1.1 Volume: 413,372		Pre. Close: 1.05 Low: 0.9101 Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	2.3	1-year :	3.06
Resists	First :	1.96	Second :	2.62
Pivot price	1.49
Supports	First :	0.91	Second :	0.75
MAs	MA(5) :	1.29	MA(20) :	1.53
	MA(100) :	6.9	MA(250) :	0
MACD	MACD :	-0.8	Signal :	-0.9
%K %D	K(14,3) :	9.2	D(3) :	20.1
RSI	RSI(14): 27.1
52-week	High :	721.75	Low :	0.91

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ NIVF ] has closed below the lower bollinger band by 1.5%. Bollinger Bands are 67% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.1 - 1.11	1.11 - 1.12
Low:	0.89 - 0.9	0.9 - 0.91
Close:	0.92 - 0.93	0.93 - 0.94

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.

Fri, 12 Dec 2025
NewGenIVF shifts Ras Al Khaimah project to joint development structure - Investing.com

Sat, 06 Dec 2025
NewGenIvf Group (NIVF) Price Target Increased by 400.00% to 76.50 - Nasdaq

Tue, 02 Dec 2025
NewGenIvf Group Sees Surprising Movement - StocksToTrade

Tue, 02 Dec 2025
NIVF: Stock Surge Raises Key Questions - timothysykes.com

Tue, 02 Dec 2025
NewGenIvf Reports Financial Turnaround and Strategic Diversification - TipRanks

Tue, 25 Nov 2025
NewGenIvf Group Announces Reverse Stock Split Effective December 1, 2025 - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Plans
Shares Out	0 (M)
Shares Float	1 (M)
Held by Insiders	429970 (%)
Held by Institutions	0.2 (%)
Shares Short	17 (K)
Shares Short P.Month	0 (K)

EPS	1
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	381.1 %
Operating Margin	-196 %
Return on Assets (ttm)	-23.1 %
Return on Equity (ttm)	160.5 %
Qtrly Rev. Growth	-12.9 %
Gross Profit (p.s.)	0.3
Sales Per Share	0.98
EBITDA (p.s.)	-0.85
Qtrly Earnings Growth	398.4 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0.92
PEG Ratio	0
Price to Book value	0
Price to Sales	0.94
Price to Cash Flow	-0.01

Dividend	0
Forward Dividend	10850
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.